New Age Alpha Advisors LLC Sells 43,647 Shares of Colgate-Palmolive Company $CL

New Age Alpha Advisors LLC decreased its holdings in Colgate-Palmolive Company (NYSE:CL) by 52.5% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 39,443 shares of the company’s stock after selling 43,647 shares during the period. New Age Alpha Advisors LLC’s holdings in Colgate-Palmolive were worth $3,117,000 as of its most recent filing with the SEC.

Other hedge funds have also bought and sold shares of the company. Maseco LLP purchased a new position in Colgate-Palmolive in the 4th quarter worth about $27,000. Copia Wealth Management purchased a new position in Colgate-Palmolive in the 3rd quarter worth about $29,000. Cloud Capital Management LLC purchased a new position in Colgate-Palmolive in the 3rd quarter worth about $30,000. Global Wealth Strategies & Associates raised its position in Colgate-Palmolive by 300.0% in the 4th quarter. Global Wealth Strategies & Associates now owns 400 shares of the company’s stock worth $32,000 after buying an additional 300 shares during the last quarter. Finally, Grove Bank & Trust raised its position in Colgate-Palmolive by 182.6% in the 4th quarter. Grove Bank & Trust now owns 407 shares of the company’s stock worth $32,000 after buying an additional 263 shares during the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Trading Up 0.1%

Shares of CL opened at $90.66 on Tuesday. The company has a debt-to-equity ratio of 16.33, a current ratio of 1.02 and a quick ratio of 0.67. Colgate-Palmolive Company has a 1 year low of $74.54 and a 1 year high of $99.33. The company has a 50 day simple moving average of $86.16 and a two-hundred day simple moving average of $85.32. The firm has a market cap of $72.74 billion, a P/E ratio of 35.28, a price-to-earnings-growth ratio of 4.71 and a beta of 0.31.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, May 1st. The company reported $0.97 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.94 by $0.03. Colgate-Palmolive had a net margin of 10.04% and a return on equity of 386.76%. The business had revenue of $5.32 billion during the quarter, compared to analyst estimates of $5.22 billion. During the same period last year, the firm posted $0.91 EPS. The company’s revenue was up 8.4% on a year-over-year basis. On average, equities analysts expect that Colgate-Palmolive Company will post 3.82 earnings per share for the current fiscal year.

Colgate-Palmolive Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, May 15th. Shareholders of record on Monday, April 20th were issued a dividend of $0.53 per share. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.52. The ex-dividend date of this dividend was Monday, April 20th. This represents a $2.12 dividend on an annualized basis and a yield of 2.3%. Colgate-Palmolive’s payout ratio is 82.49%.

Analysts Set New Price Targets

A number of equities analysts have weighed in on CL shares. Barclays boosted their target price on Colgate-Palmolive from $79.00 to $80.00 and gave the stock an “equal weight” rating in a research report on Tuesday, May 5th. Royal Bank Of Canada reissued an “outperform” rating and issued a $102.00 target price on shares of Colgate-Palmolive in a research report on Monday, May 4th. Piper Sandler decreased their target price on Colgate-Palmolive from $96.00 to $92.00 and set an “overweight” rating for the company in a research report on Wednesday, April 8th. The Goldman Sachs Group reaffirmed a “buy” rating on shares of Colgate-Palmolive in a research report on Friday, May 1st. Finally, Citigroup upped their price target on shares of Colgate-Palmolive from $95.00 to $105.00 and gave the company a “buy” rating in a research report on Monday, February 2nd. Twelve investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $95.88.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.